Modulators of Crth-2 Receptor Activity for the Treatment of Prostaglandin D2 Mediated Diseases
申请人:Bonnert Victor Roger
公开号:US20070249686A1
公开(公告)日:2007-10-25
The invention relates to substituted acids as useful pharmaceutical compounds for treating respiratory disorders as asthma, pharmaceutical compositions containing them, and processes for their preparation.
MODULATORS OF CRTH2 REZEPTOR ACTIVITY FOR THE TREATMENT OF PROSTAGLANDIN D2 MEDIATED DISEASES
申请人:AstraZeneca AB
公开号:EP1799658A2
公开(公告)日:2007-06-27
[EN] NOVEL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSES
申请人:ASTRAZENECA AB
公开号:WO2006037982A2
公开(公告)日:2006-04-13
The invention relates to substituted acids as useful pharmaceutical compounds for treating respiratory disorders as asthma, pharmaceutical compositions containing them, and processes for their preparation.